Sramana Mitra: What else is interesting and what’s worth highlighting in your entrepreneurial journey from a lessons from the trenches point of view? Kris Duggan: There are probably a million directions we could go. One thing I would say as being very important is to be very focused as a company. I think we decided
Sramana Mitra: It sounds like at this point, you have decided on the positioning and the target market. You started generating revenue. You hit the million dollar mark. What’s the next major inflection point? Mikko Valimaki: One important point in the early days was, we were also talking with venture capital. When we got the
Sramana Mitra: You didn’t really have any proof point yet. You didn’t have a product out. You didn’t have anything going. You just got a concept financing of $15 million from Kleiner. Kris Duggan: The fact that I was in the process of having those 80 conversations and mapping the market was critical to the
Sramana Mitra: You basically were putting embedded code on the devices for filesystem management. Mikko Valimaki: Yes. Looking back, I think we made the right choice. We were able to grow really fast in the selected Asian market. When we were in the open source stage, I would say that from the early revenue, it
Entrepreneurs are invited to the 308th FREE online 1M/1M roundtable mentoring session on Thursday, June 9, 2016, at 8 a.m. PDT/11 a.m. EDT/8:30 p.m. India IST. If you are a serious entrepreneur, register to “pitch” and sell your business idea to Sramana Mitra. You’ll gain straightforward feedback, advice on next steps, and she’ll answer any
In case you missed it, you can listen to the recording here: 307th Roundtable Recording On May 19, 2016: With Anand Daniel, Accel Partners
During this week’s roundtable, our guest was Anand Daniel, Partner with Accel Partners, who discussed Accel India’s investment strategy at length. i-Human Patients As for the pitches, first up, 1M/1M Premium member Norm Wu from Sunnyvale, CA, pitched i-Human Patients. The company did $2.2M in bookings in 2015 for its SaaS medical simulation product selling
Sramana Mitra: Was there a segment where you were finding traction from a size point of view or any other segmentation parameter? Kris Duggan: I would say that initially when I first started the company, I thought this might be for companies that are not too big. Maybe if you’re a thousand or ten thousand